Maarten J. Beekman MD , Lara Terra MD , Bernadette A.M. Heemskerk-Gerritsen PhD , Carlijn M. van der Aalst PhD , Jeanine E. Roeters van Lennep MD, PhD , Marc van Beurden MD, PhD , Helena C. van Doorn MD, PhD , Joanne A. de Hullu MD, PhD , Eleonora B.L. van Dorst MD , Constantijne H. Mom MD, PhD , Marian J.E. Mourits MD, PhD , Brigitte F.M. Slangen MD, PhD , Annemarieke Bartels-Rutten MD, PhD , Ricardo P.J. Budde MD, PhD , Miranda M. Snoeren MD , Tim Leiner MD, PhD , Pim A. de Jong MD, PhD , Rozemarijn Vliegenthart MD, PhD , R. Nils Planken MD, PhD , Casper Mihl MD, PhD , Flora E. van Leeuwen PhD
{"title":"Coronary Artery Calcium Scores After Prophylactic Premenopausal Bilateral Salpingo-Oophorectomy","authors":"Maarten J. Beekman MD , Lara Terra MD , Bernadette A.M. Heemskerk-Gerritsen PhD , Carlijn M. van der Aalst PhD , Jeanine E. Roeters van Lennep MD, PhD , Marc van Beurden MD, PhD , Helena C. van Doorn MD, PhD , Joanne A. de Hullu MD, PhD , Eleonora B.L. van Dorst MD , Constantijne H. Mom MD, PhD , Marian J.E. Mourits MD, PhD , Brigitte F.M. Slangen MD, PhD , Annemarieke Bartels-Rutten MD, PhD , Ricardo P.J. Budde MD, PhD , Miranda M. Snoeren MD , Tim Leiner MD, PhD , Pim A. de Jong MD, PhD , Rozemarijn Vliegenthart MD, PhD , R. Nils Planken MD, PhD , Casper Mihl MD, PhD , Flora E. van Leeuwen PhD","doi":"10.1016/j.jaccao.2024.09.011","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Premenopausal risk-reducing salpingo-oophorectomy (RRSO) in women at high familial risk of ovarian cancer leads to immediate menopause. Although early natural menopause is associated with increased cardiovascular disease risk, evidence on long-term cardiovascular disease risk after early surgical menopause is scarce.</div></div><div><h3>Objectives</h3><div>We sought to determine the long-term influence of the timing of RRSO on the development of coronary artery calcium (CAC), an established marker for cardiovascular disease risk.</div></div><div><h3>Methods</h3><div>We conducted a cross-sectional study (N = 733) nested in a nationwide cohort of women at high familial risk of ovarian cancer. In women aged 60-70 years (n = 328), we compared CAC scores between women with a premenopausal RRSO (age ≤45 years) and women with a postmenopausal RRSO (age ≥54 years), using multivariable Poisson analyses. Within the premenopausal RRSO group (n = 498), we also examined the effect of age at RRSO. In addition, we compared the premenopausal RRSO group with an external reference cohort (n = 5,226).</div></div><div><h3>Results</h3><div>Multivariable analyses showed that the prevalence rates of any CAC (CAC >0), at least moderate CAC (CAC >100), and severe CAC (CAC >400) were comparable between the premenopausal and postmenopausal RRSO groups (relative risk [RR]: 0.93; 95% CI: 0.75-1.15 for any CAC; RR: 0.71; 95% CI: 0.43-1.17 for at least moderate CAC; RR: 0.81; 95% CI: 0.30-2.13 for severe CAC). There was no difference in CAC between the premenopausal RRSO group and a similar aged reference cohort. Timing of premenopausal RRSO (early premenopausal RRSO [<41 years] vs late premenopausal RRSO [41-45 years]) did not affect the outcomes.</div></div><div><h3>Conclusions</h3><div>Our results do not show a long-term adverse effect of surgical menopause on the development of CAC.</div></div>","PeriodicalId":48499,"journal":{"name":"Jacc: Cardiooncology","volume":"6 6","pages":"Pages 922-931"},"PeriodicalIF":12.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711998/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jacc: Cardiooncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666087324003557","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Premenopausal risk-reducing salpingo-oophorectomy (RRSO) in women at high familial risk of ovarian cancer leads to immediate menopause. Although early natural menopause is associated with increased cardiovascular disease risk, evidence on long-term cardiovascular disease risk after early surgical menopause is scarce.
Objectives
We sought to determine the long-term influence of the timing of RRSO on the development of coronary artery calcium (CAC), an established marker for cardiovascular disease risk.
Methods
We conducted a cross-sectional study (N = 733) nested in a nationwide cohort of women at high familial risk of ovarian cancer. In women aged 60-70 years (n = 328), we compared CAC scores between women with a premenopausal RRSO (age ≤45 years) and women with a postmenopausal RRSO (age ≥54 years), using multivariable Poisson analyses. Within the premenopausal RRSO group (n = 498), we also examined the effect of age at RRSO. In addition, we compared the premenopausal RRSO group with an external reference cohort (n = 5,226).
Results
Multivariable analyses showed that the prevalence rates of any CAC (CAC >0), at least moderate CAC (CAC >100), and severe CAC (CAC >400) were comparable between the premenopausal and postmenopausal RRSO groups (relative risk [RR]: 0.93; 95% CI: 0.75-1.15 for any CAC; RR: 0.71; 95% CI: 0.43-1.17 for at least moderate CAC; RR: 0.81; 95% CI: 0.30-2.13 for severe CAC). There was no difference in CAC between the premenopausal RRSO group and a similar aged reference cohort. Timing of premenopausal RRSO (early premenopausal RRSO [<41 years] vs late premenopausal RRSO [41-45 years]) did not affect the outcomes.
Conclusions
Our results do not show a long-term adverse effect of surgical menopause on the development of CAC.
期刊介绍:
JACC: CardioOncology is a specialized journal that belongs to the esteemed Journal of the American College of Cardiology (JACC) family. Its purpose is to enhance cardiovascular care for cancer patients by publishing high-quality, innovative scientific research and sharing evidence-based knowledge.
The journal aims to revolutionize the field of cardio-oncology and actively involve and educate professionals in both cardiovascular and oncology fields. It covers a wide range of topics including pre-clinical, translational, and clinical research, as well as best practices in cardio-oncology. Key areas of focus include understanding disease mechanisms, utilizing in vitro and in vivo models, exploring novel and traditional therapeutics (across Phase I-IV trials), studying epidemiology, employing precision medicine, and investigating primary and secondary prevention.
Amyloidosis, cardiovascular risk factors, heart failure, and vascular disease are some examples of the disease states that are of particular interest to the journal. However, it welcomes research on other relevant conditions as well.